Proteomic and Metabolomic Profiling in Soft Tissue Sarcomas

Abstract excerpt

OPINION STATEMENT: Advances in proteomic and metabolomic technologies have accelerated our understanding of multiple aspects of cancer biology across distinct tumour types. Here we review the current state-of-the-art in the use of proteomics and metabolomics in soft tissue sarcomas. We highlight the utility of these Omics-based methodologies to identify new drug targets, synthetic lethal interactions, candidate...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Cardiac tumors and thrombi
• Share to Sarcoma Diagnosis and Treatment
• Share to Vascular Tumors and Angiosarcomas